A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer

By Oh Sung Yong   Kwon Hyuk-Chan   Seo Bong-Gun   Kim Sung-Hyun   Kim Jae-Seok   Kim Hyo-Jin  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 336-341

Informa Healthcare

Access to resources Recommend Favorite

Phase I Study of Weekly Cisplatin, Bolus Fluorouracil and Escalating Doses of Irinotecan in Advanced Solid Tumors

By Ku Geoffrey   O'Reilly Eileen   Saltz Leonard   Schrag Deborah   Maki Robert   Kelsen David   Ilson David  

Cancer Investigation, Vol. 27, Iss. 4, 2009-05 ,pp. : 402-406

Informa Healthcare

Access to resources Recommend Favorite

Oxaliplatin with High-dose Leucovorin and 5-Fluorouracil 48-hour Continuous Infusion in Pretreated Metastatic Colorectal Cancer

By de Gramont A.   Vignoud J.   Tournigand C.   Louvet C.   Andre T.   Varette C.   Raymond E.   Moreau S.   Le Bail N.   Krulik M.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 214-219

Elsevier

Access to resources Recommend Favorite

A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomas

By Caroli-Bosc F.X.   Van Laethem J.L.   Michel P.   Gay F.   Hendlisz A.   Forget F.   Bleiberg H.  

European Journal of Cancer, Vol. 37, Iss. 15, 2001-10 ,pp. : 1828-1832

Elsevier

Access to resources Recommend Favorite

Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer

By Polee M.B.   Verweij J.   Siersema P.D.   Tilanus H.W.   Splinter T.A.W.   Stoter G.   Van der Gaast A.  

European Journal of Cancer, Vol. 38, Iss. 11, 2002-07 ,pp. : 1495-1500

Elsevier

Access to resources Recommend Favorite